These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

813 related items for PubMed ID: 11083258

  • 1. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials.
    Charles PJ, Smeenk RJ, De Jong J, Feldmann M, Maini RN.
    Arthritis Rheum; 2000 Nov; 43(11):2383-90. PubMed ID: 11083258
    [Abstract] [Full Text] [Related]

  • 2. Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy.
    De Rycke L, Kruithof E, Van Damme N, Hoffman IE, Van den Bossche N, Van den Bosch F, Veys EM, De Keyser F.
    Arthritis Rheum; 2003 Apr; 48(4):1015-23. PubMed ID: 12687543
    [Abstract] [Full Text] [Related]

  • 3. Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity: biologic and clinical implications in autoimmune arthritis.
    De Rycke L, Baeten D, Kruithof E, Van den Bosch F, Veys EM, De Keyser F.
    Arthritis Rheum; 2005 Jul; 52(7):2192-201. PubMed ID: 15986349
    [Abstract] [Full Text] [Related]

  • 4. Evolution of antinuclear antibodies and clinical patterns in patients with active rheumatoid arthritis with longterm infliximab therapy.
    Comby E, Tanaff P, Mariotte D, Costentin-Pignol V, Marcelli C, Ballet JJ.
    J Rheumatol; 2006 Jan; 33(1):24-30. PubMed ID: 16395746
    [Abstract] [Full Text] [Related]

  • 5. Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNF alpha.
    Eriksson C, Engstrand S, Sundqvist KG, Rantapää-Dahlqvist S.
    Ann Rheum Dis; 2005 Mar; 64(3):403-7. PubMed ID: 15297281
    [Abstract] [Full Text] [Related]

  • 6. Chimeric anti-tumor necrosis factor-alpha monoclonal antibody treatment of patients with rheumatoid arthritis receiving methotrexate therapy.
    Kavanaugh A, St Clair EW, McCune WJ, Braakman T, Lipsky P.
    J Rheumatol; 2000 Apr; 27(4):841-50. PubMed ID: 10782805
    [Abstract] [Full Text] [Related]

  • 7. Diagnosing systemic lupus erythematosus: new-generation immunoassays for measurement of anti-dsDNA antibodies are an effective alternative to the Farr technique and the Crithidia luciliae immunofluorescence test.
    Antico A, Platzgummer S, Bassetti D, Bizzaro N, Tozzoli R, Villalta D, Study Group on Autoimmune Diseases of the Italian Society of Laboratory Medicine (SIMeL).
    Lupus; 2010 Jul; 19(8):906-12. PubMed ID: 20179169
    [Abstract] [Full Text] [Related]

  • 8. Effects of short-term infliximab therapy on autoantibodies in systemic lupus erythematosus.
    Aringer M, Steiner G, Graninger WB, Höfler E, Steiner CW, Smolen JS.
    Arthritis Rheum; 2007 Jan; 56(1):274-9. PubMed ID: 17195231
    [Abstract] [Full Text] [Related]

  • 9. Clinical significance of ELISA positive and immunofluorescence negative anti-dsDNA antibody.
    Kim KH, Han JY, Kim JM, Lee SW, Chung WT.
    Clin Chim Acta; 2007 May 01; 380(1-2):182-5. PubMed ID: 17355877
    [Abstract] [Full Text] [Related]

  • 10. Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis.
    De Rycke L, Verhelst X, Kruithof E, Van den Bosch F, Hoffman IE, Veys EM, De Keyser F.
    Ann Rheum Dis; 2005 Feb 01; 64(2):299-302. PubMed ID: 15166003
    [Abstract] [Full Text] [Related]

  • 11. IgG and IgM anticardiolipin antibodies following treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis.
    Visvanathan S, Wagner C, Smolen J, St Clair EW, Hegedus R, Baker D, Keenan G.
    Arthritis Rheum; 2006 Sep 01; 54(9):2840-4. PubMed ID: 16948115
    [Abstract] [Full Text] [Related]

  • 12. Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab.
    Bendtzen K, Geborek P, Svenson M, Larsson L, Kapetanovic MC, Saxne T.
    Arthritis Rheum; 2006 Dec 01; 54(12):3782-9. PubMed ID: 17133559
    [Abstract] [Full Text] [Related]

  • 13. Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment.
    Bobbio-Pallavicini F, Alpini C, Caporali R, Avalle S, Bugatti S, Montecucco C.
    Arthritis Res Ther; 2004 Dec 01; 6(3):R264-72. PubMed ID: 15142273
    [Abstract] [Full Text] [Related]

  • 14. Autoantibodies, metalloproteinases and bone markers in rheumatoid arthritis patients are unable to predict their responses to infliximab.
    Lequerré T, Jouen F, Brazier M, Clayssens S, Klemmer N, Ménard JF, Mejjad O, Daragon A, Tron F, Le Loët X, Vittecoq O.
    Rheumatology (Oxford); 2007 Mar 01; 46(3):446-53. PubMed ID: 16899502
    [Abstract] [Full Text] [Related]

  • 15. Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study.
    Aringer M, Graninger WB, Steiner G, Smolen JS.
    Arthritis Rheum; 2004 Oct 01; 50(10):3161-9. PubMed ID: 15476222
    [Abstract] [Full Text] [Related]

  • 16. Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement.
    Alessandri C, Bombardieri M, Papa N, Cinquini M, Magrini L, Tincani A, Valesini G.
    Ann Rheum Dis; 2004 Oct 01; 63(10):1218-21. PubMed ID: 15361374
    [Abstract] [Full Text] [Related]

  • 17. Treatment with infliximab plus methotrexate improves anemia in patients with rheumatoid arthritis independent of improvement in other clinical outcome measures-a pooled analysis from three large, multicenter, double-blind, randomized clinical trials.
    Doyle MK, Rahman MU, Han C, Han J, Giles J, Bingham CO, Bathon J.
    Semin Arthritis Rheum; 2009 Oct 01; 39(2):123-31. PubMed ID: 18823645
    [Abstract] [Full Text] [Related]

  • 18. Autoantibodies profile of rheumatoid arthritis patients during treatment with infliximab.
    Elkayam O, Burke M, Vardinon N, Zakut V, Yitzhak RB, Paran D, Levartovsky D, Litinsky I, Caspi D.
    Autoimmunity; 2005 Mar 01; 38(2):155-60. PubMed ID: 16040336
    [Abstract] [Full Text] [Related]

  • 19. A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunity.
    Poulalhon N, Begon E, Lebbé C, Lioté F, Lahfa M, Bengoufa D, Morel P, Dubertret L, Bachelez H.
    Br J Dermatol; 2007 Feb 01; 156(2):329-36. PubMed ID: 17223874
    [Abstract] [Full Text] [Related]

  • 20. High sensitive detection of double-stranded DNA autoantibodies by a modified Crithidia luciliae immunofluorescence test.
    Conrad K, Ittenson A, Reinhold D, Fischer R, Roggenbuck D, Büttner T, Bosselmann HP, Steinbach J, Schössler W.
    Ann N Y Acad Sci; 2009 Sep 01; 1173():180-5. PubMed ID: 19758148
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.